BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 28, 2008
View Archived Issues
Amgen Earnings Beat Estimates, But ESA Uncertainty Looms
Despite regulatory and reimbursement challenges to its erythropoietin stimulating agent (ESA) franchise, Amgen Inc. beat analyst estimates for earnings in the fourth quarter of 2007. (BioWorld Today)
Read More
Nuvelo Still Seeking Efficacy of Thrombolytic Drug Alfimeprase
Read More
Research Firms Up Alzheimer's Connection to Blood Flow Issues
Read More
FDA Taking Proactive Approach in Detecting Psychiatric Effects
Read More
MiddleBrook to Raise $21M in Private Placement Offering
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More